Workshop Date and Time

Monday, May 24, 2021, 1:30 – 2:30 pm, Eastern Time Register Now

Registrants can listen in live over the phone or online as a webcast.

Topics Covered

  • Why Diagnostic Technologies Are Important for Blood Cancers, in the Context of COVID-19
  • How They Contribute to & Transform Your Blood Cancer Treatments
  • New & Emerging Diagnostic Technologies
  • How to Participate in Blood Cancer Clinical Trials
  • Specific Questions to Ask the Healthcare Team about Diagnostic Technologies
  • Accessing Resources for Blood Cancer Clinical Trials
  • Guide to Preparing for Your Telehealth/Telemedicine Appointments, including Technology & List of Prepared Questions
  • Questions for Our Panel of Experts

Our Panel of Experts

Peter Martin, MD

Chief, Lymphoma Program, Associate Professor of Medicine, Weill Cornell Medicine, Associate Attending Physician, NewYork-Presbyterian Hospital

Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine

William I. Bensinger, MD

Center for Blood Disorders and Stem Cell Transplantation, SCI’s Personalized Medicine Program, Myeloma & Transplant Program, Swedish Cancer Institute

Ruben A. Mesa, MD, FACP

Executive Director, Mays Cancer Center at UT Health San Antonio MD Anderson, Mays Family Foundation Distinguished University Presidential Chair, Professor of Medicine, UT Health San Antonio Cancer Center – An NCI Designated Cancer Center

Elizabeth K. O’Donnell, MD

Director, Lifestyle Clinic, Massachusetts General Hospital, Associate Director, Mass General Cancer Center’s Survivorship Program, Assistant Professor of Medicine, Harvard Medical School

Joseph Khoury, MD, FCAP

Professor, Division of Pathology & Lab Medicine, Department of Hematopathology, Medical Director, Clinical Expansion, Division of Pathology & Lab Medicine, Executive Director, MD Anderson Cancer Network, Division of Pathology & Lab Medicine, The University of Texas M. D. Anderson Cancer Center

Sarah Thibault-Sennett, PhD

Senior Manager of Public Policy and Advocacy, Association for Molecular Pathology (AMP)

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare

Continuing Education Credits

(Live Only)

Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.

CancerCare, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.

Registered Dietitians: This program has been submitted to the Commission on Dietetic Registration for one Continuing Professional Education Unit (CPEU).

To request continuing education paperwork, please email your name, profession, and address to connect@cancercare.org after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.

Brochure

You can download the brochure for this workshop(pdf)(96.3 KB)

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.